inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation

PURPOSE: Accumulating evidence suggests that inhibitors of aldose reductase (AR) may prevent hyperglycemia-induced long-term complications in diabetes mellitus. In the present study, we evaluated the AR inhibitory potential of ethanolic (EtOH) extracts from 22 seaweed species. METHODS: AR inhibitory...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of nutrition 2014-02, Vol.53 (1), p.233-242
Hauptverfasser: Islam, Md. Nurul, Choi, Sung Hwa, Moon, Hye Eun, Park, Jin Ju, Jung, Hyun Ah, Woo, Mi Hee, Woo, Hee Chul, Choi, Jae Sue
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 242
container_issue 1
container_start_page 233
container_title European journal of nutrition
container_volume 53
creator Islam, Md. Nurul
Choi, Sung Hwa
Moon, Hye Eun
Park, Jin Ju
Jung, Hyun Ah
Woo, Mi Hee
Woo, Hee Chul
Choi, Jae Sue
description PURPOSE: Accumulating evidence suggests that inhibitors of aldose reductase (AR) may prevent hyperglycemia-induced long-term complications in diabetes mellitus. In the present study, we evaluated the AR inhibitory potential of ethanolic (EtOH) extracts from 22 seaweed species. METHODS: AR inhibitory activities of the selected seaweed species were evaluated using the rat lens aldose reductase (RLAR) inhibitory assay. RESULTS: All extracts exhibited RLAR inhibitory activity, which ranged from 5.87 to 92.71 % at a concentration of 50 μg/mL. Since Capsosiphon fulvescens exhibited significant inhibitory potential and is a frequently used foodstuff, it was selected for a detailed investigation using RLAR and advanced glycation end products (AGE) formation inhibitory assays. Among the different solvent-soluble fractions, the CH₂Cl₂, EtOAc, and n-BuOH fractions showed promising RLAR and AGE formation inhibitory activities. Considering the AR inhibitory potential, CH₂Cl₂ and EtOAc fractions were selected for chromatographic separation and yielded 11 compounds in which capsofulvesin A, capsofulvesin B, and chalinasterol showed potential RLAR inhibitory activity with the respective IC₅₀ values of 52.53, 101.92, and 345.27 μM. Kinetic studies revealed that capsofulvesin A and chalinasterol exhibited mixed type inhibition, while capsofulvesin B exhibited noncompetitive inhibition. To our knowledge, this is the first report of AR inhibitory activity of the glycolipids capsofulvesin A and capsofulvesin B. CONCLUSIONS: Our results clearly indicate the potential RLAR and AGE formation inhibitory activities of C. fulvescens as well as its isolated constituents, which could be further explored to develop therapeutic modalities for the treatment of diabetes and related complications.
doi_str_mv 10.1007/s00394-013-0521-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1493800779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1493800779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-b52626af5d743a1cf59926af153f0e0653381174c89affa2b759f3f349683b483</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEou3CD-ACllAlLgF_xsmxWvElVeIAPVsTx9515bUXO1kp_4KfjEOWgjhwsDweP-94PG9VvSD4LcFYvssYs47XmLAaC0rq-VF1SThr6oYS8fghxvKiusr5HmNMWUOeVheUCSmkxJfVDxf2rndjTDMCPbqTG53JKFo07g0yg-u9QbtkTEDgd4C2cMwxu-M-BmQnfzJZm1D4gBKMyC8x-CFmg5IZJj1CiSAMCIYTBG0GtPOzhtEVgSnpY4oLlZGN6fAr_ax6YsFn8_y8b6q7D--_bT_Vt18-ft7e3Naa02ase0Eb2oAVg-QMiLai65YzEcxigxvBWEuI5LrtwFqgvRSdZZbxrmlZz1u2qd6sdUsL3yeTR3Vw5S_eQzBxyorwjrVlyLIr6Ot_0Ps4pVC6WyjactGUwW4qslI6xZyTseqY3AHSrAhWi11qtUsVu9Ril5qL5uW58tQfzPCg-O1PAa7PAGQN3qYyRJf_cC2VWDJWOLpyuVyFnUl_tfif11-tIgtRwS6VwndfKSYclyVa1rGfOa24DA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1492845602</pqid></control><display><type>article</type><title>inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Islam, Md. Nurul ; Choi, Sung Hwa ; Moon, Hye Eun ; Park, Jin Ju ; Jung, Hyun Ah ; Woo, Mi Hee ; Woo, Hee Chul ; Choi, Jae Sue</creator><creatorcontrib>Islam, Md. Nurul ; Choi, Sung Hwa ; Moon, Hye Eun ; Park, Jin Ju ; Jung, Hyun Ah ; Woo, Mi Hee ; Woo, Hee Chul ; Choi, Jae Sue</creatorcontrib><description>PURPOSE: Accumulating evidence suggests that inhibitors of aldose reductase (AR) may prevent hyperglycemia-induced long-term complications in diabetes mellitus. In the present study, we evaluated the AR inhibitory potential of ethanolic (EtOH) extracts from 22 seaweed species. METHODS: AR inhibitory activities of the selected seaweed species were evaluated using the rat lens aldose reductase (RLAR) inhibitory assay. RESULTS: All extracts exhibited RLAR inhibitory activity, which ranged from 5.87 to 92.71 % at a concentration of 50 μg/mL. Since Capsosiphon fulvescens exhibited significant inhibitory potential and is a frequently used foodstuff, it was selected for a detailed investigation using RLAR and advanced glycation end products (AGE) formation inhibitory assays. Among the different solvent-soluble fractions, the CH₂Cl₂, EtOAc, and n-BuOH fractions showed promising RLAR and AGE formation inhibitory activities. Considering the AR inhibitory potential, CH₂Cl₂ and EtOAc fractions were selected for chromatographic separation and yielded 11 compounds in which capsofulvesin A, capsofulvesin B, and chalinasterol showed potential RLAR inhibitory activity with the respective IC₅₀ values of 52.53, 101.92, and 345.27 μM. Kinetic studies revealed that capsofulvesin A and chalinasterol exhibited mixed type inhibition, while capsofulvesin B exhibited noncompetitive inhibition. To our knowledge, this is the first report of AR inhibitory activity of the glycolipids capsofulvesin A and capsofulvesin B. CONCLUSIONS: Our results clearly indicate the potential RLAR and AGE formation inhibitory activities of C. fulvescens as well as its isolated constituents, which could be further explored to develop therapeutic modalities for the treatment of diabetes and related complications.</description><identifier>ISSN: 1436-6207</identifier><identifier>EISSN: 1436-6215</identifier><identifier>DOI: 10.1007/s00394-013-0521-y</identifier><identifier>PMID: 23575770</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>aldehyde reductase ; Aldehyde Reductase - antagonists &amp; inhibitors ; Aldehyde Reductase - metabolism ; Animals ; Biological and medical sciences ; Capsosiphon ; Chemistry ; Chemistry and Materials Science ; Chlorophyta - chemistry ; chromatography ; diabetes mellitus ; Diabetes Mellitus - prevention &amp; control ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Enzyme Inhibitors - pharmacology ; ethanol ; ethyl acetate ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Eye and associated structures. Visual pathways and centers. Vision ; Feeding. Feeding behavior ; foods ; Fundamental and applied biological sciences. Psychology ; glycation ; Glycation End Products, Advanced - antagonists &amp; inhibitors ; Glycation End Products, Advanced - metabolism ; glycolipids ; inhibitory concentration 50 ; Lens, Crystalline - drug effects ; Lens, Crystalline - enzymology ; macroalgae ; Medical sciences ; Nutrition ; Original Contribution ; Plant Extracts - pharmacology ; Rats ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vertebrates: nervous system and sense organs</subject><ispartof>European journal of nutrition, 2014-02, Vol.53 (1), p.233-242</ispartof><rights>Springer-Verlag Berlin Heidelberg 2013</rights><rights>2015 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-b52626af5d743a1cf59926af153f0e0653381174c89affa2b759f3f349683b483</citedby><cites>FETCH-LOGICAL-c426t-b52626af5d743a1cf59926af153f0e0653381174c89affa2b759f3f349683b483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00394-013-0521-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00394-013-0521-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28270733$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23575770$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Islam, Md. Nurul</creatorcontrib><creatorcontrib>Choi, Sung Hwa</creatorcontrib><creatorcontrib>Moon, Hye Eun</creatorcontrib><creatorcontrib>Park, Jin Ju</creatorcontrib><creatorcontrib>Jung, Hyun Ah</creatorcontrib><creatorcontrib>Woo, Mi Hee</creatorcontrib><creatorcontrib>Woo, Hee Chul</creatorcontrib><creatorcontrib>Choi, Jae Sue</creatorcontrib><title>inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation</title><title>European journal of nutrition</title><addtitle>Eur J Nutr</addtitle><addtitle>Eur J Nutr</addtitle><description>PURPOSE: Accumulating evidence suggests that inhibitors of aldose reductase (AR) may prevent hyperglycemia-induced long-term complications in diabetes mellitus. In the present study, we evaluated the AR inhibitory potential of ethanolic (EtOH) extracts from 22 seaweed species. METHODS: AR inhibitory activities of the selected seaweed species were evaluated using the rat lens aldose reductase (RLAR) inhibitory assay. RESULTS: All extracts exhibited RLAR inhibitory activity, which ranged from 5.87 to 92.71 % at a concentration of 50 μg/mL. Since Capsosiphon fulvescens exhibited significant inhibitory potential and is a frequently used foodstuff, it was selected for a detailed investigation using RLAR and advanced glycation end products (AGE) formation inhibitory assays. Among the different solvent-soluble fractions, the CH₂Cl₂, EtOAc, and n-BuOH fractions showed promising RLAR and AGE formation inhibitory activities. Considering the AR inhibitory potential, CH₂Cl₂ and EtOAc fractions were selected for chromatographic separation and yielded 11 compounds in which capsofulvesin A, capsofulvesin B, and chalinasterol showed potential RLAR inhibitory activity with the respective IC₅₀ values of 52.53, 101.92, and 345.27 μM. Kinetic studies revealed that capsofulvesin A and chalinasterol exhibited mixed type inhibition, while capsofulvesin B exhibited noncompetitive inhibition. To our knowledge, this is the first report of AR inhibitory activity of the glycolipids capsofulvesin A and capsofulvesin B. CONCLUSIONS: Our results clearly indicate the potential RLAR and AGE formation inhibitory activities of C. fulvescens as well as its isolated constituents, which could be further explored to develop therapeutic modalities for the treatment of diabetes and related complications.</description><subject>aldehyde reductase</subject><subject>Aldehyde Reductase - antagonists &amp; inhibitors</subject><subject>Aldehyde Reductase - metabolism</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Capsosiphon</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chlorophyta - chemistry</subject><subject>chromatography</subject><subject>diabetes mellitus</subject><subject>Diabetes Mellitus - prevention &amp; control</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>ethanol</subject><subject>ethyl acetate</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Eye and associated structures. Visual pathways and centers. Vision</subject><subject>Feeding. Feeding behavior</subject><subject>foods</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>glycation</subject><subject>Glycation End Products, Advanced - antagonists &amp; inhibitors</subject><subject>Glycation End Products, Advanced - metabolism</subject><subject>glycolipids</subject><subject>inhibitory concentration 50</subject><subject>Lens, Crystalline - drug effects</subject><subject>Lens, Crystalline - enzymology</subject><subject>macroalgae</subject><subject>Medical sciences</subject><subject>Nutrition</subject><subject>Original Contribution</subject><subject>Plant Extracts - pharmacology</subject><subject>Rats</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>1436-6207</issn><issn>1436-6215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kU1v1DAQhiMEou3CD-ACllAlLgF_xsmxWvElVeIAPVsTx9515bUXO1kp_4KfjEOWgjhwsDweP-94PG9VvSD4LcFYvssYs47XmLAaC0rq-VF1SThr6oYS8fghxvKiusr5HmNMWUOeVheUCSmkxJfVDxf2rndjTDMCPbqTG53JKFo07g0yg-u9QbtkTEDgd4C2cMwxu-M-BmQnfzJZm1D4gBKMyC8x-CFmg5IZJj1CiSAMCIYTBG0GtPOzhtEVgSnpY4oLlZGN6fAr_ax6YsFn8_y8b6q7D--_bT_Vt18-ft7e3Naa02ase0Eb2oAVg-QMiLai65YzEcxigxvBWEuI5LrtwFqgvRSdZZbxrmlZz1u2qd6sdUsL3yeTR3Vw5S_eQzBxyorwjrVlyLIr6Ot_0Ps4pVC6WyjactGUwW4qslI6xZyTseqY3AHSrAhWi11qtUsVu9Ril5qL5uW58tQfzPCg-O1PAa7PAGQN3qYyRJf_cC2VWDJWOLpyuVyFnUl_tfif11-tIgtRwS6VwndfKSYclyVa1rGfOa24DA</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Islam, Md. Nurul</creator><creator>Choi, Sung Hwa</creator><creator>Moon, Hye Eun</creator><creator>Park, Jin Ju</creator><creator>Jung, Hyun Ah</creator><creator>Woo, Mi Hee</creator><creator>Woo, Hee Chul</creator><creator>Choi, Jae Sue</creator><general>Springer-Verlag</general><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RQ</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20140201</creationdate><title>inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation</title><author>Islam, Md. Nurul ; Choi, Sung Hwa ; Moon, Hye Eun ; Park, Jin Ju ; Jung, Hyun Ah ; Woo, Mi Hee ; Woo, Hee Chul ; Choi, Jae Sue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-b52626af5d743a1cf59926af153f0e0653381174c89affa2b759f3f349683b483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>aldehyde reductase</topic><topic>Aldehyde Reductase - antagonists &amp; inhibitors</topic><topic>Aldehyde Reductase - metabolism</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Capsosiphon</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chlorophyta - chemistry</topic><topic>chromatography</topic><topic>diabetes mellitus</topic><topic>Diabetes Mellitus - prevention &amp; control</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>ethanol</topic><topic>ethyl acetate</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Eye and associated structures. Visual pathways and centers. Vision</topic><topic>Feeding. Feeding behavior</topic><topic>foods</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>glycation</topic><topic>Glycation End Products, Advanced - antagonists &amp; inhibitors</topic><topic>Glycation End Products, Advanced - metabolism</topic><topic>glycolipids</topic><topic>inhibitory concentration 50</topic><topic>Lens, Crystalline - drug effects</topic><topic>Lens, Crystalline - enzymology</topic><topic>macroalgae</topic><topic>Medical sciences</topic><topic>Nutrition</topic><topic>Original Contribution</topic><topic>Plant Extracts - pharmacology</topic><topic>Rats</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Islam, Md. Nurul</creatorcontrib><creatorcontrib>Choi, Sung Hwa</creatorcontrib><creatorcontrib>Moon, Hye Eun</creatorcontrib><creatorcontrib>Park, Jin Ju</creatorcontrib><creatorcontrib>Jung, Hyun Ah</creatorcontrib><creatorcontrib>Woo, Mi Hee</creatorcontrib><creatorcontrib>Woo, Hee Chul</creatorcontrib><creatorcontrib>Choi, Jae Sue</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Career &amp; Technical Education Database</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Islam, Md. Nurul</au><au>Choi, Sung Hwa</au><au>Moon, Hye Eun</au><au>Park, Jin Ju</au><au>Jung, Hyun Ah</au><au>Woo, Mi Hee</au><au>Woo, Hee Chul</au><au>Choi, Jae Sue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation</atitle><jtitle>European journal of nutrition</jtitle><stitle>Eur J Nutr</stitle><addtitle>Eur J Nutr</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>53</volume><issue>1</issue><spage>233</spage><epage>242</epage><pages>233-242</pages><issn>1436-6207</issn><eissn>1436-6215</eissn><abstract>PURPOSE: Accumulating evidence suggests that inhibitors of aldose reductase (AR) may prevent hyperglycemia-induced long-term complications in diabetes mellitus. In the present study, we evaluated the AR inhibitory potential of ethanolic (EtOH) extracts from 22 seaweed species. METHODS: AR inhibitory activities of the selected seaweed species were evaluated using the rat lens aldose reductase (RLAR) inhibitory assay. RESULTS: All extracts exhibited RLAR inhibitory activity, which ranged from 5.87 to 92.71 % at a concentration of 50 μg/mL. Since Capsosiphon fulvescens exhibited significant inhibitory potential and is a frequently used foodstuff, it was selected for a detailed investigation using RLAR and advanced glycation end products (AGE) formation inhibitory assays. Among the different solvent-soluble fractions, the CH₂Cl₂, EtOAc, and n-BuOH fractions showed promising RLAR and AGE formation inhibitory activities. Considering the AR inhibitory potential, CH₂Cl₂ and EtOAc fractions were selected for chromatographic separation and yielded 11 compounds in which capsofulvesin A, capsofulvesin B, and chalinasterol showed potential RLAR inhibitory activity with the respective IC₅₀ values of 52.53, 101.92, and 345.27 μM. Kinetic studies revealed that capsofulvesin A and chalinasterol exhibited mixed type inhibition, while capsofulvesin B exhibited noncompetitive inhibition. To our knowledge, this is the first report of AR inhibitory activity of the glycolipids capsofulvesin A and capsofulvesin B. CONCLUSIONS: Our results clearly indicate the potential RLAR and AGE formation inhibitory activities of C. fulvescens as well as its isolated constituents, which could be further explored to develop therapeutic modalities for the treatment of diabetes and related complications.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23575770</pmid><doi>10.1007/s00394-013-0521-y</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1436-6207
ispartof European journal of nutrition, 2014-02, Vol.53 (1), p.233-242
issn 1436-6207
1436-6215
language eng
recordid cdi_proquest_miscellaneous_1493800779
source MEDLINE; SpringerNature Journals
subjects aldehyde reductase
Aldehyde Reductase - antagonists & inhibitors
Aldehyde Reductase - metabolism
Animals
Biological and medical sciences
Capsosiphon
Chemistry
Chemistry and Materials Science
Chlorophyta - chemistry
chromatography
diabetes mellitus
Diabetes Mellitus - prevention & control
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Enzyme Inhibitors - pharmacology
ethanol
ethyl acetate
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Eye and associated structures. Visual pathways and centers. Vision
Feeding. Feeding behavior
foods
Fundamental and applied biological sciences. Psychology
glycation
Glycation End Products, Advanced - antagonists & inhibitors
Glycation End Products, Advanced - metabolism
glycolipids
inhibitory concentration 50
Lens, Crystalline - drug effects
Lens, Crystalline - enzymology
macroalgae
Medical sciences
Nutrition
Original Contribution
Plant Extracts - pharmacology
Rats
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vertebrates: nervous system and sense organs
title inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A44%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=inhibitory%20activities%20of%20the%20edible%20green%20alga%20Capsosiphon%20fulvescens%20on%20rat%20lens%20aldose%20reductase%20and%20advanced%20glycation%20end%20products%20formation&rft.jtitle=European%20journal%20of%20nutrition&rft.au=Islam,%20Md.%20Nurul&rft.date=2014-02-01&rft.volume=53&rft.issue=1&rft.spage=233&rft.epage=242&rft.pages=233-242&rft.issn=1436-6207&rft.eissn=1436-6215&rft_id=info:doi/10.1007/s00394-013-0521-y&rft_dat=%3Cproquest_cross%3E1493800779%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1492845602&rft_id=info:pmid/23575770&rfr_iscdi=true